India, Nov. 3 -- Hyderabad-based HRV Pharma (HRV Global Life Sciences), a global virtual pharmaceutical company, has entered into definitive agreements to acquire 100 per cent of the equity of Phatebo GmbH from ZeroStack Corp.

Phatebo is a licensed pharmaceutical company based in Hilzingen, Germany, specialising in clinical trial supply, with revenues of approximately Rs 350 crore in 2025. The terms of the transaction were not disclosed. The acquisition takes HRV beyond active pharmaceutical ingredients into finished formulations, and gives HRV a licensed operating business in Germany.

Every clinical trial depends on more than the new therapy being tested. Sponsors also need a reliable supply of comparator medicines, usually approved br...